ElevateBio Stock

ElevateBio is a biotechnology company that specializes in cell and gene-based therapies.

Sign up today and learn more about ElevateBio Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About ElevateBio Stock

ElevateBio is an operator of a portfolio of cell and gene therapy companies intended to develop, manufacture, and commercialize life-transforming medicines. The company creates a portfolio through partnerships with the world's innovative scientists and inventors as well as it created a centralized facility that integrates all the elements that translate cell and gene therapy R&D into commercially viable therapies quickly and efficiently, enabling patients to get medical products to treat severe diseases. Vikas Sinha, Mitchell Finer, and David Hallal co-founded ElevateBio in Cambridge, Massachusetts in 2017.

Funding History

May 2019$150M
March 2020$170M
March 2021$525M
May 2023$401M


CEO, Chair, & Co-Founder

David Hallal

Chief Scientific Officer

Mitchell Finer

Chief Financial Officer

Vikas Sinha

Chief Business Officer

Kareem Reda

CSO, Regenerative Medicine

Melissa Carpenter

Chief Development Officer

Agustin Melian

Senior Vice President, CMC Operations

Michael Paglia

SVP of Research and Development

Jill Mooney

Board Member

Karan Takhar

Board Member

Khalil Barrage

Chief Operating Officer,

Michael Paglia

Board Member

Ansbert Gadicke

Board Member

Mario G. Giuliani

Board Member

Deep Nishar

Board Member

Morana Jovan-Embiricos

Board Member

Navneet Govil

VP, Head of Program Management

Brian Majors


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: